The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Golumbeski George since year 2005.
The trader's CIK number is 1586660.
At the time of this reporting, Golumbeski George is the Director of Enanta Pharmaceuticals Inc .
(stock ticker symbol ENTA).
See this page for all insider trading activities at Enanta Pharmaceuticals Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-03-04||ENTA||Enanta Pharmaceuticals Inc||Sale||9,280||103.65||961,899|
|2019-03-04||ENTA||Enanta Pharmaceuticals Inc||Option Ex||9,280||36.61||339,740|
|2019-02-12||ENTA||Enanta Pharmaceuticals Inc||Sale||11,228||90.07||1,011,305|
|2019-02-11||ENTA||Enanta Pharmaceuticals Inc||Sale||2,272||90.03||204,552|
|2019-02-12||ENTA||Enanta Pharmaceuticals Inc||Option Ex||11,228||27.30||306,524|
|2019-02-11||ENTA||Enanta Pharmaceuticals Inc||Option Ex||2,272||25.58||58,117|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Golumbeski George (Director of Enanta Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.